COMMUNIQUÉS West-GlobeNewswire

CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand
17/09/2026
U.S. Centers for Disease Control and Prevention (CDC) Reports a Significant Year-Over-Year Increase in Nationwide Rabies Exposures and Rabies Immunoglobulin Utilization KedRAB is One of Only Two FDA-Approved Anti-Rabies [...]
Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026
17/09/2026
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced [...]
Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team
17/09/2026
Latest publication adds to growing body of clinical evidence supporting hybrid IVUS-OCT imaging in complex coronary procedures Chief Technology Officer Amandeep Thind to lead continued innovation TORONTO, Sept. 17, 2026 [...]
Two Herbalists Spent Six Years Formulating an Energy Bar. Here's Why It Took That Long.
17/09/2026
ILA launches Chocolate and Peanut adaptogenic energy bars, the first products from a formulation process co-founders Amy Saleh and Eileen Brantley refused to rush ATLANTA, GA , Sept. 17, 2026 (GLOBE NEWSWIRE) -- Most [...]
Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award
17/09/2026
Global GIL Recognition Spotlights Apeloa’s End-to-End "API + Drug Product" Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated Markets SHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH
17/09/2026
RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH The 2026 Award, open to early career investigators from around the world, was dedicated to advancing research in [...]
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
17/09/2026
Yale physician-scientist and biotech entrepreneur Dr. Ranjit Bindra brings deep expertise in DNA repair, synthetic lethality and brain tumor therapeutics VANCOUVER, British Columbia, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients
17/09/2026
COPENHAGEN, Denmark, Sept. 17, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced that the first patient has been enrolled in Part 2 of the Phase 1b/2a clinical trial of SNIPR001 (NCT06938867), the Company's lead CRISPR- [...]
RAMSAY SANTE Group unveils "Connecting Care 2030"
17/09/2026
PRESS RELEASE Paris, 17 September 2026 Ramsay Santé Group unveils “Connecting Care 2030” to drive next phase of profitable growth and create long term value for all stakeholders “Connecting Care 2030”, Ramsay Santé [...]
Le Groupe RAMSAY SANTE dévoile "Connecting Care 2030"
17/09/2026
COMMUNIQUÉ DE PRESSE Paris, le 17 septembre 2026 Le groupe Ramsay Santé dévoile « Connecting Care 2030 », pour accélérer sa croissance rentable et créer de la valeur durable pour l’ensemble de ses parties prenantes « [...]
Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic
17/09/2026
COPENHAGEN, Denmark, September 17, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Tarja Stenvall has been appointed President and Chief Executive Officer, effective October 15, 2026, succeeding Paul Chaplin [...]
Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice
17/09/2026
Patient experience data (PED) are direct insights that patients provide on their symptoms, quality of life, treatment preferences and unmet needs. PED Essentials is an online learning hub, co-created with patients and [...]
Roche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO study
17/09/2026
Phase III CELESTIMO study met its primary endpoint at the interim analysis demonstrating a statistically significant and clinically meaningful reduction in the risk of disease progression in people with follicular [...]
Desert Hope Treatment Center Names Blaise Schafer Lead Clinician for New First Responders Program
17/09/2026
LAS VEGAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center has named Blaise Schafer, LCSW, lead clinician for its new First Responders Program at its residential treatment facility in Las Vegas. The [...]
MEDVi QUAD Formula Update Confirmed for 2026: Apomorphine Replaces PT-141 in Current 4-in-1 Combination
17/09/2026
Sildenafil, Tadalafil, Apomorphine, and L-Citrulline Confirmed as MEDVi's Current QUAD Formulation for Compounded ED Treatment Newark, DE, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not FDA-approved [...]
AdCare Hospital Promotes Lilly Cabral to Role of Clinical Director
17/09/2026
WORCESTER, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- AdCare Hospital, a leading provider of medical detox and addiction treatment services in Worcester, MA, has appointed Lilly Cabral, M.A., LADC-I, as the Clinical [...]
COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING
17/09/2026
TORONTO, ONTARIO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) is pleased to announce, further to the press release dated September 10, 2026, [...]
Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling
16/09/2026
Available now, this new proprietary dispensing capability lets customers order the exact single-use bag sizes and quantities their process requires, released as a single lot with one Certificate of Analysis, with no [...]
Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
16/09/2026
Company Announces Exploration of All Options to Maximize Shareholder Value The top line results showed that the ELPIS II trial did not meet its primary endpoint of improvement in right ventricular ejection fraction ( [...]

Pages